Emcure Pharmaceuticals consolidated net profit rises 43.64% in the June 2025 quarter
Sales rise 15.72% to Rs 2100.54 crore
Net profit of Emcure Pharmaceuticals rose 43.64% to Rs 206.95 crore in the quarter ended June 2025 as against Rs 144.08 crore during the previous quarter ended June 2024. Sales rose 15.72% to Rs 2100.54 crore in the quarter ended June 2025 as against Rs 1815.14 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales2100.541815.14 16 OPM %19.8418.53 -PBDT393.71301.00 31 PBT294.26207.41 42 NP206.95144.08 44Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 07 2025 | 2:02 PM IST